- Home
- LAES vs KMDA Comparison
LAES vs KMDA Comparison
Compare LAES & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- KMDA
- Stock Information
- Founded
- LAES 2022
- KMDA 1990
- Country
- LAES Switzerland
- KMDA Israel
- Employees
- LAES N/A
- KMDA N/A
- Industry
- LAES Semiconductors
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- KMDA Health Care
- Exchange
- LAES Nasdaq
- KMDA Nasdaq
- Market Cap
- LAES 366.0M
- KMDA 410.6M
- IPO Year
- LAES N/A
- KMDA N/A
- Fundamental
- Price
- LAES $3.44
- KMDA $7.03
- Analyst Decision
- LAES Strong Buy
- KMDA Strong Buy
- Analyst Count
- LAES 1
- KMDA 2
- Target Price
- LAES $6.00
- KMDA $13.00
- AVG Volume (30 Days)
- LAES 5.7M
- KMDA 47.6K
- Earning Date
- LAES 09-25-2025
- KMDA 11-12-2025
- Dividend Yield
- LAES N/A
- KMDA 2.84%
- EPS Growth
- LAES N/A
- KMDA 27.97
- EPS
- LAES N/A
- KMDA 0.32
- Revenue
- LAES $10,978,000.00
- KMDA $169,517,000.00
- Revenue This Year
- LAES N/A
- KMDA $14.49
- Revenue Next Year
- LAES N/A
- KMDA $10.12
- P/E Ratio
- LAES N/A
- KMDA $21.23
- Revenue Growth
- LAES N/A
- KMDA 9.67
- 52 Week Low
- LAES $0.31
- KMDA $5.17
- 52 Week High
- LAES $11.00
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- LAES 69.08
- KMDA 46.61
- Support Level
- LAES $2.49
- KMDA $6.80
- Resistance Level
- LAES $3.54
- KMDA $7.27
- Average True Range (ATR)
- LAES 0.20
- KMDA 0.19
- MACD
- LAES 0.12
- KMDA 0.00
- Stochastic Oscillator
- LAES 90.48
- KMDA 36.51
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.